Subcutaneous (SC) Bortezomib-Regimens for Patients With RR MM Failing Prior IV Bortezomib-Containing Regimens

NCT01695330 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated by Sponsor of this study.

Conditions

Multiple Myeloma

Interventions

DRUG: Subcutaneous bortezomib

Sponsor

Oncotherapeutics

Collaborators

[object Object]